Compare JHX & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JHX | ALGN |
|---|---|---|
| Founded | 1888 | 1997 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 11.9B |
| IPO Year | N/A | N/A |
| Metric | JHX | ALGN |
|---|---|---|
| Price | $21.55 | $170.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | $27.33 | ★ $179.09 |
| AVG Volume (30 Days) | ★ 4.7M | 1.1M |
| Earning Date | 02-17-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.40 | ★ 5.16 |
| Revenue | ★ $4,116,899,999.00 | $3,982,622,000.00 |
| Revenue This Year | $24.54 | $2.58 |
| Revenue Next Year | $15.32 | $3.36 |
| P/E Ratio | $62.60 | ★ $32.31 |
| Revenue Growth | ★ 4.60 | 0.56 |
| 52 Week Low | $16.46 | $122.00 |
| 52 Week High | $29.83 | $237.23 |
| Indicator | JHX | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 62.77 | 71.88 |
| Support Level | $20.43 | $154.62 |
| Resistance Level | $21.05 | $159.16 |
| Average True Range (ATR) | 0.60 | 3.57 |
| MACD | 0.01 | 0.40 |
| Stochastic Oscillator | 72.43 | 92.11 |
James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Following the Azek acquisition in 2025, it also produces wooden composite decking materials, siding trims, and accessories for outdoor areas including stair and deck railing. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.